MYD88 and neoplasm: Moreover, Prinzing et al. have demonstrated that CAR T-cells with introduced MyD88 and CD40 signaling domains into the CAR endodomain enhanced CAR T-cell function in in vitro models during repeated stimulation and also in in vivo tumor models.